During the past decade, Kohler & Milstein Research conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kohler & Milstein Research" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "BioNTech SE" with 1 trials sponsored, "CanSino Biologics Inc." with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kohler & Milstein Research" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Beijing Institute of Biotechnology" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kohler & Milstein Research" are "COVID-19" (4 trials), "Rheumatoid Arthritis" (4 trials), "Psoriasis" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Kohler & Milstein Research" in a lesser frequency.

Most popular intervention types in "Kohler & Milstein Research" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (2 trials), "Mirikizumab" (2 trials), "PF-07321332" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kohler & Milstein Research" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Kohler & Milstein Research". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kohler & Milstein Research, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kohler & Milstein Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".